Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Gains from Investment Securities (2016 - 2025)

National Healthcare (NHC) has disclosed Gains from Investment Securities for 16 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 56.47% year-over-year to $3.6 million, compared with a TTM value of $17.6 million through Dec 2025, up 32.94%, and an annual FY2025 reading of $3.6 million, up 1110.95% over the prior year.
  • Gains from Investment Securities was $3.6 million for Q4 2025 at National Healthcare, up from $876161.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $8.3 million in Q4 2024 and bottomed at -$25.9 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is -$240034.3, with a median of $551848.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities soared 19016.67% in 2022, then tumbled 530.3% in 2023.
  • Year by year, Gains from Investment Securities stood at -$25.9 million in 2021, then surged by 100.56% to $144000.0 in 2022, then surged by 3900.0% to $5.8 million in 2023, then surged by 43.8% to $8.3 million in 2024, then crashed by 56.47% to $3.6 million in 2025.
  • Business Quant data shows Gains from Investment Securities for NHC at $3.6 million in Q4 2025, $876161.0 in Q1 2025, and $8.3 million in Q4 2024.